抗反流手术与不同组织学类型肺癌风险的多国队列研究
该多国队列研究纳入丹麦、芬兰、冰岛、挪威和瑞典1980-2014年间接受抗反流手术的患者,比较其与背景人群及未手术胃食管反流病(GERD)患者的肺癌风险。结果显示抗反流手术与肺小细胞癌和鳞状细胞癌风险降低相关,但与肺腺癌风险无关。
要点
- 抗反流手术与肺小细胞癌风险降低相关(SIR=0.57,95%CI 0.41-0.77)。
- 抗反流手术与肺鳞状细胞癌风险降低相关(SIR=0.75,95%CI 0.60-0.92)。
- 抗反流手术与肺腺癌风险无关(SIR=0.90,95%CI 0.76-1.06)。
核心结论
- 接受抗反流手术的患者肺小细胞癌和鳞状细胞癌风险降低,但肺腺癌风险未降低。
研究设计与样本
- 基于人群的队列研究,纳入1980-2014年间在丹麦、芬兰、冰岛、挪威或瑞典接受抗反流手术的患者。
- 共纳入812,617例GERD患者,其中46,996例(5.8%)接受过抗反流手术。
- 比较抗反流手术患者与背景人群(计算标准化发病比SIR)及未手术GERD患者(计算风险比HR,多变量Cox回归调整 sex、age、calendar period、country、COPD、obesity诊断或2型糖尿病)。
主要发现
- 与背景人群相比,肺小细胞癌SIR=0.57(95%CI 0.41-0.77),肺鳞状细胞癌SIR=0.75(95%CI 0.60-0.92),肺腺癌SIR=0.90(95%CI 0.76-1.06)。
- 与未手术GERD患者相比,肺小细胞癌HR=0.63(95%CI 0.44-0.90),肺鳞状细胞癌HR=0.80(95%CI 0.62-1.03),肺腺癌HR=1.03(95%CI 0.84-1.26)。
- 限定于客观GERD(反流性食管炎或Barrett食管)患者的分析显示相似结果。
临床怎么用
- 对于接受抗反流手术的GERD患者,应关注其肺小细胞癌和鳞状细胞癌风险降低的潜在关联,但肺腺癌风险未见降低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Airway micro-aspiration might contribute to the proposed associations between gastroesophageal reflux disease (GERD) and some lung diseases, including lung cancer. This study aimed to examine the hypothesis that antireflux surgery decreases the risk of small cell carcinoma, squamous cell carcinoma and adenocarcinoma of the lung differently depending on their location in relation to micro-aspiration. METHODS: Population-based cohort study including patients having undergone antireflux surgery during 1980-2014 in Denmark, Finland, Iceland, Norway or Sweden. Patients having undergone antireflux surgery were compared with two groups: 1) the corresponding background population, by calculating standardised incidence ratios (SIRs) with 95% confidence intervals (CIs) and 2) non-operated GERD-patients, by calculating hazard ratios (HRs) with 95% CIs using multivariable Cox regression with adjustment for sex, age, calendar period, country, chronic obstructive pulmonary disease and obesity diagnosis or type 2 diabetes. RESULTS: Among all 812,617 GERD-patients, 46,996 (5.8%) had undergone antireflux surgery. The SIRs were statistically significantly decreased for small cell carcinoma (SIR = 0.57, 95% CI 0.41-0.77) and squamous cell carcinoma (SIR = 0.75, 95% CI 0.60-0.92), but not for adenocarcinoma of the lung (SIR = 0.90, 95% CI 0.76-1.06). The HRs were also below unity for small cell carcinoma (HR = 0.63, 95% CI 0.44-0.90) and squamous cell carcinoma (HR = 0.80, 95% CI 0.62-1.03), but not for adenocarcinoma of the lung (HR = 1.03, 95% CI 0.84-1.26). Analyses restricted to patients with objective GERD (reflux oesophagitis or Barrett's oesophagus) showed similar results. CONCLUSIONS: This all-Nordic study indicates that patients who undergo antireflux surgery are at decreased risk of small cell carcinoma and squamous cell carcinoma of the lung, but not of adenocarcinoma of the lung.
引用
- Yanes M, Santoni G, Maret-Ouda J, et al. Antireflux surgery and risk of lung cancer by histological type in a multinational cohort study. Eur J Cancer. 2020. PMID: 32877797. doi:10.1016/j.ejca.2020.07.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。